A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients
Clinical trial NCT06732960 · COMPLETED
Trial details
- NCT number
- NCT06732960
- Sponsor
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-21
- Primary completion
- 2024-11-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.